Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Wei-Ru Cho"'
Autor:
Wei-Ru Cho, Chih-Chi Wang, Mu-Jung Tsai, Chih-Che Lin, Yi-Hao Yen, Chien Hung Chen, Yuan-Hung Kuo, Chih-Chien Yao, Chao-Hung Hung, Pao-Yuan Huang, An-Che Liu, Ming-Chao Tsai
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 18 (2024)
Background: The risk of first recurrence of hepatocellular carcinoma (HCC) within years 5 to 10 after curative hepatectomy remains unknown. We aimed to assess the incidence and prognostic factors for very late recurrence among patients who achieved 5
Externí odkaz:
https://doaj.org/article/bbb17fa5e8f546c48bec8f2975145a64
Autor:
Yu-Chieh Tsai, Fai-Meng Sou, Yueh-Wei Liu, Yi-Ju Wu, Chee-Chien Yong, Ding-Wei Chen, Pao-Yuan Huang, Wei-Ru Cho, Ching-Hui Chuang, Chang-Chun Hsiao, Tsung-Hui Hu, Ming-Chao Tsai
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background The albumin–bilirubin (ALBI) grade has been validated as a significant prognostic predictor for hepatocellular carcinoma (HCC). However, there is little information about the ALBI grade in patients with non-B non-C HCC (NBNC-HCC
Externí odkaz:
https://doaj.org/article/3dcac68e63b24408b4555537b8b40c60
Publikováno v:
Viruses, Vol 15, Iss 3, p 786 (2023)
Early detection and prompt linkage to care are critical for hepatocellular carcinoma (HCC) care. Chang Gung Memorial Hospital (CGMH) Yunlin branch, a local hospital in a rural area, undertakes health checkup programs in addition to its routine clinic
Externí odkaz:
https://doaj.org/article/57c99adf48dd4f8f82919e4e7d73978d
Autor:
Wei-Ru Cho, Chih-Chi Wang, Meng-Yun Tsai, Chen-Kai Chou, Yueh-Wei Liu, Yi-Ju Wu, Ming-Tsung Lin, Kuang-Den Chen, Ching-Hui Chuang, Pao-Yuan Huang, Tsung-Hui Hu, Ming-Chao Tsai
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0247231 (2021)
BackgroundMetformin is proposed to have chemopreventive effect of various cancer currently. However, the anti-cancer effect of metformin for diabetic patients with hepatocellular carcinoma (HCC) undergoing liver resection remains unclear. The aim of
Externí odkaz:
https://doaj.org/article/2e0e24afe7e8402da8a89c88835664da
Autor:
Meng-Yun Tsai, Yi-Hao Yen, Pao-Yuan Huang, Fai-Meng Sou, Chih-Che Lin, Wei-Ru Cho, Hsin-Ming Wang, Ding-Wei Chen, Kuo-Chin Chang, Cheng-Kun Wu, Tsung-Hui Hu, Ming-Chao Tsai
Publikováno v:
Gastroenterology Research and Practice, Vol 2019 (2019)
Background and Aim. Liver fibrosis is associated with the prognosis of patients with hepatocellular carcinoma (HCC) after resection. The fibrosis-4 (FIB-4) index is an accurate and noninvasive marker to determine the degree of liver fibrosis. Here, w
Externí odkaz:
https://doaj.org/article/320d883534ba4f09a158e9a505826062
Autor:
Chih-Chi Wang, Yu-Chieh Tsai, Tsung-Hui Hu, Ming-Chao Tsai, Yueh-Wei Liu, Chien-Hung Chen, Wei-Ru Cho, Chee-Chien Yong, Chih-Che Lin, Yi-Ju Wu, Chao-Hung Hung, Kuang-Den Chen
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports
Scientific Reports
The albumin-bilirubin (ALBI) grade has been validated as a significant predictor for hepatocellular carcinoma (HCC). However, there is little information about the impact of postoperative ALBI grade in patients with HCC who are undergoing liver resec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7278e6a9e61460cb03ffa766de24b137
http://link.springer.com/article/10.1038/s41598-020-64354-0
http://link.springer.com/article/10.1038/s41598-020-64354-0
Autor:
Ding-Wei Chen, Wei-Ru Cho, Yu-Chieh Tsai, Yueh-Wei Liu, Chee-Chien Yong, Fai-Meng Sou, Ching-Hui Chuang, Yi-Ju Wu, Pao-Yuan Huang, Tsung-Hui Hu, Ming-Chao Tsai, Chang-Chun Hsiao
Publikováno v:
BMC Gastroenterology
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-9 (2021)
Background The albumin–bilirubin (ALBI) grade has been validated as a significant prognostic predictor for hepatocellular carcinoma (HCC). However, there is little information about the ALBI grade in patients with non-B non-C HCC (NBNC-HCC) receivi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a52276dc1cc0770fd64532acb8e834e
https://doi.org/10.1186/s12876-021-01944-w
https://doi.org/10.1186/s12876-021-01944-w
Autor:
Pao-Yuan Huang, Wei-Ru Cho, Ding-Wei Chen, Chih-Chi Wang, Shu-Hsien Lin, Yen-Po Lin, Chih-Che Lin, Chao-Hung Hung, Ming-Chao Tsai, Yu-Syuan Chen, Shih-Yu Yang, Ching-Hui Chuang
Publikováno v:
Journal of Personalized Medicine
Volume 11
Issue 8
Journal of Personalized Medicine, Vol 11, Iss 684, p 684 (2021)
Volume 11
Issue 8
Journal of Personalized Medicine, Vol 11, Iss 684, p 684 (2021)
Backgrounds and Aim: Metabolic-associated fatty liver dis-ease (MAFLD) is a novel term proposed in 2020 to avoid the exclusion of certain subpopulations, though the application of this term in the real world is very limited. Here, we aimed to evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::198e9b21e7f531841b6d6267487530c3
http://europepmc.org/articles/PMC8398387
http://europepmc.org/articles/PMC8398387
Autor:
Ching-Hui Chuang, Meng-Yun Tsai, Kuang-Den Chen, Tsung-Hui Hu, Wei-Ru Cho, Chen-Kai Chou, Chih-Chi Wang, Ming-Chao Tsai, Yi-Ju Wu, Pao-Yuan Huang, Yueh-Wei Liu, Ming-Tsung Lin
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0247231 (2021)
PLoS ONE
PLoS ONE
Background Metformin is proposed to have chemopreventive effect of various cancer currently. However, the anti-cancer effect of metformin for diabetic patients with hepatocellular carcinoma (HCC) undergoing liver resection remains unclear. The aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::696757de89509586b581aacc73e683fb
https://doaj.org/article/2e0e24afe7e8402da8a89c88835664da
https://doaj.org/article/2e0e24afe7e8402da8a89c88835664da
Autor:
Cheng-Kun Wu, Meng-Yun Tsai, Wei-Ru Cho, Kuo-Chin Chang, Pao-Yuan Huang, Ming-Chao Tsai, Ding-Wei Chen, Hsin-Ming Wang, Tsung-Hui Hu, Chih-Che Lin, Fai-Meng Sou, Yi-Hao Yen
Publikováno v:
Gastroenterology Research and Practice
Gastroenterology Research and Practice, Vol 2019 (2019)
Gastroenterology Research and Practice, Vol 2019 (2019)
Background and Aim. Liver fibrosis is associated with the prognosis of patients with hepatocellular carcinoma (HCC) after resection. The fibrosis-4 (FIB-4) index is an accurate and noninvasive marker to determine the degree of liver fibrosis. Here, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eb4a468f97b9e3e61604c5513e4fae8
https://pubmed.ncbi.nlm.nih.gov/31885547
https://pubmed.ncbi.nlm.nih.gov/31885547